MedPath

ANUZINC HC PLUS

ANUZINC HC PLUS

Dormant
DIN Number

02242797

Drug Class

Human

Market Date

Mar 1, 2001

Company
HC

Laboratoires Confab Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02242797
AIG Number0314223002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C05AA51 HYDROCORTISONE, COMBINATIONS
Product Specifications
Dosage FormSuppository
Route of AdministrationRectal
AHFS Classification84:06.00
Health Canada Classification

ACTIVE INGREDIENTS (3)

HYDROCORTISONE ACETATEActive
Strength: 10 MG
Monograph: HYDROCORTISONE ACETATE
PRAMOXINE HYDROCHLORIDEActive
Strength: 20 MG
Monograph: PRAMOXINE HYDROCHLORIDE
ZINC SULFATEActive
Strength: 10 MG
Monograph: ZINC SULFATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.